The medtech company will receive the state funds once it has accomplished its promise to create 120 new jobs at the site.
latest articles
The money will leave the urology company debt-free and provide board member Lewis Pell with enough stock to assume 33 percent ownership.
Analysis: Highest rate increases will be from national carriers with co-ops and Blues not far behind.
Anthony Cataldo of Oxis Biotech touts immunotherapies targeting lymphoma and leukemia.
Is this harmony in health care?
Some lodging businesses remain confident that tourism numbers will remain strong through the fall.
The company hopes the semantic coding specialist will help push its electronic health records system to market in other countries.
Construction on the six-block research, education, commercial and product development space is set to start in late 2017.
There are now legal commitments to pay for the local share of the $1.858 billion project. But in keeping with so much of the process surrounding the planning of Southwest LRT, it wasn’t easy.
The final eight companies will move on for the chance to win $50,000 in seed capital.
Some tips for managing those annual forays into strategy and vision.
The best opportunities for networking this month.
The school claimed Gilead Sciences used a drug it developed to create and heavily profit off of Hepatitis C medications.
Medical properties are seen as solid investments.
New report adds to evidence that employees are paying more for their own care.
Diagnostic kit-maker DiaSorin tapped by U.S. to roll out test, process results.